Sung Hee Choi

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 10

Top Topics

Epithelial Mesenchymal Transition

Transforming Growth Factor

Top Venues

Cancer communications (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Sung Hee Choi, Jay Thomas Myers, Suzanne Louise Tomchuck, Melissa Bonner, Saada Eid, Daniel Tyler Kingsley, Kristen Ashley VanHeyst, Seong-Jin Kim, Byung-Gyu Kim, Alex Yee-Chen Huang
Oral transforming growth factor-beta receptor 1 inhibitor vactosertib promotes osteosarcoma regression by targeting tumor proliferation and enhancing anti-tumor immunity. Cancer communications (London, England) (2024)
Sung Hee Choi, Jay Thomas Myers, Suzanne Louise Tomchuck, Melissa Bonner, Saada Eid, Daniel Tyler Kingsley, Kristen Ashley VanHeyst, Seong-Jin Kim, Byung-Gyu Kim, Alex Yee-Chen Huang
Oral transforming growth factor-beta receptor 1 inhibitor vactosertib promotes osteosarcoma regression by targeting tumor proliferation and enhancing anti-tumor immunity. Cancer communications (London, England) 44 (8) (2024)
Sung Hee Choi, Jay Thomas Myers, Suzanne Louise Tomchuck, Melissa Bonner, Saada Eid, Daniel Tyler Kingsley, Kristen Ashley VanHeyst, Seong-Jin Kim, Byung-Gyu Kim, Alex Yee-Chen Huang
Oral transforming growth factor-beta receptor 1 inhibitor vactosertib promotes osteosarcoma regression by targeting tumor proliferation and enhancing anti-tumor immunity. Cancer communications (London, England) 44 (8) (2024)
Sung Hee Choi, Jay Thomas Myers, Suzanne Louise Tomchuck, Melissa Bonner, Saada Eid, Daniel Tyler Kingsley, Kristen Ashley VanHeyst, Seong-Jin Kim, Byung-Gyu Kim, Alex Yee-Chen Huang
Oral transforming growth factor-beta receptor 1 inhibitor vactosertib promotes osteosarcoma regression by targeting tumor proliferation and enhancing anti-tumor immunity. Cancer communications (London, England) (2024)
Sung Hee Choi, Jay Thomas Myers, Suzanne Louise Tomchuck, Melissa Bonner, Saada Eid, Daniel Tyler Kingsley, Kristen Ashley VanHeyst, Seong-Jin Kim, Byung-Gyu Kim, Alex Yee-Chen Huang
Oral transforming growth factor-beta receptor 1 inhibitor vactosertib promotes osteosarcoma regression by targeting tumor proliferation and enhancing anti-tumor immunity. Cancer communications (London, England) 44 (8) (2024)
Sung Hee Choi, Jay Thomas Myers, Suzanne Louise Tomchuck, Melissa Bonner, Saada Eid, Daniel Tyler Kingsley, Kristen Ashley VanHeyst, Seong-Jin Kim, Byung-Gyu Kim, Alex Yee-Chen Huang
Oral transforming growth factor-beta receptor 1 inhibitor vactosertib promotes osteosarcoma regression by targeting tumor proliferation and enhancing anti-tumor immunity. Cancer communications (London, England) 44 (8) (2024)
Muta Abiff, Mohammad Alshebremi, Melissa Bonner, Jay T Myers, Byung-Gyu Kim, Suzanne L Tomchuck, Alicia Santin, Daniel T Kingsley, Sung Hee Choi, Alex Yee-Chen Huang
Piezo1 facilitates optimal T cell activation during tumor challenge. Oncoimmunology 12 (1) (2023)
Muta Abiff, Mohammad Alshebremi, Melissa Bonner, Jay T Myers, Byung-Gyu Kim, Suzanne L Tomchuck, Alicia Santin, Daniel T Kingsley, Sung Hee Choi, Alex Yee-Chen Huang
Piezo1 facilitates optimal T cell activation during tumor challenge. Oncoimmunology 12 (1) (2023)
Muta Abiff, Mohammad Alshebremi, Melissa Bonner, Jay T Myers, Byung-Gyu Kim, Suzanne L Tomchuck, Alicia Santin, Daniel T Kingsley, Sung Hee Choi, Alex Yee-Chen Huang
Piezo1 facilitates optimal T cell activation during tumor challenge. Oncoimmunology 12 (1) (2023)
Muta Abiff, Mohammad Alshebremi, Melissa Bonner, Jay T Myers, Byung-Gyu Kim, Suzanne L Tomchuck, Alicia Santin, Daniel T Kingsley, Sung Hee Choi, Alex Yee-Chen Huang
Piezo1 facilitates optimal T cell activation during tumor challenge. Oncoimmunology 12 (1) (2023)